Delisting of Securities of GTC Biotherapeutics From The NASDAQ Stock Market

NEW YORK, May 17, 2010 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the common stock of GTC Biotherapeutics Inc. GTC Biotherapeutics Inc.'s stock was suspended on March 19, 2010 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company's securities are trading on another venue, please review the company's public filings or contact the company directly.

Back to news